• Empathy Plant Co. has signed certified plant-based nutritionist, Melissa Melnychuk as their official spokesperson
  • Melissa is a Certified Holistic Health Coach (CHHC) and a Plant-Based Certified expert from Cornell University
  • Melissa will be primarily responsible for influencing 18 to 24-year-old females who account for 48% of the plant-based product market
  • Canbud Distribution Corporation (CBDX) is a science and technology health and wellness company
  • Canbud opened trading at C$0.17 per share

Canbud Distribution Corporation (CBDX)  subsidiary, Empathy Plant Co. has signed certified plant-based nutritionist, Melissa Melnychuk as their official spokesperson.

Melissa is a Certified Holistic Health Coach (CHHC) and a Plant-Based Certified expert from Cornell University.

Melissa started her practice in 2010 and has worked with women from all walks of life including entrepreneurs, travelling executives, stay-at-home moms, former fitness competitors, professional athletes and more.

 As an advocate for body positivity and the ‘diet culture dropout’ movement, she reflects the Empathy Plant Co. culture and messaging tone of inclusivity and change through thoughtful conversations.

Melissa commented,

“When I was approached to help support and build the Empathy Plant Co. brand I jumped at the opportunity. Not only am I familiar with the entrepreneurial team behind the brand, but their character and vision are something I am completely aligned with.

Other current plant-based protein offerings are not speaking to the largest target market and the team has given me the opportunity to do so. The more people I can turn on to the plant-based lifestyle, the more people I can help and that fuels my soul.

With the Canbud and Empathy team by my side I’m stoked to help people live healthier and happy lives.”

As part of Empathy Plant Co.’s marketing strategy, Melissa will be responsible for speaking to and influencing the largest segment in the plant-based space, 18 to 24-year-old females who account for 48% of the market.

As Empathy Plant Co. pushes to commercialize, the credibility of her accomplishments will help build consumer confidence and drive sales.

Canbud VP of Marketing and CPG (Consumer Packaged Goods) expert, Adrian Burke commented,

“I have known Melissa for over a decade and have watched her execute at a high level as a savvy business person. Her passion for helping others is something that stands out the most, along with her caring and nurturing qualities, she has given me all the confidence she’ll appeal greatly to the largest segment of plant-based consumers.”

Empathy will also be leveraging Melissa’s experience and insight in exploring plant-based drink options further enriching their innovation pipeline. With the production of their Complete Plant Protein well underway, Empathy Plant Co. is strongly positioned in the plant-based product segment which is anticipated to witness the fastest growth in the protein market over the forecasted period (2020-2027).

According to a market report published by Meticulous Research®, the plant-based protein supplements market is expected to grow at a CAGR of 7.8% from 2020 to 2027 to reach $9.57 billion by 2027.

Canbud has granted 600,000 incentive stock options to 2 consultants of the corporation. The options have an exercise price of 22 cents and a term of four years expiring on March 30, 2025.

Canbud Distribution Corporation (CBDX) is a science and technology health and wellness company that encompasses plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals.

Canbud opened trading at C$0.17 per share.

More From The Market Online

Tilray’s Breckenridge Brewery honours Denver Nuggets with new ale

Tilray Brands (TSX:TLRY) subsidiary Breckenridge Brewery launches a new ale to recognize the 2023 NBA championship-winning Denver Nuggets.

Avicanna launches 10% CBD (THC free) formula in Canada

Avicanna (TSX:AVCN) launches RHO Phyto Micro Drop 100, a 10 per cent CBD (THC free), proprietary oral formulation in Canada.

Organigram looks to raise capital as cannabis stocks surge

Organigram (TSX:OGI), one of Canada's first cannabis stocks, announces an overnight marketed public offering of units for up to C$25 million.